Mr. Speaker, I forgot to mention that I will be splitting my time with the member for Winnipeg North.
Testing, as we all know, plays a key role in our efforts to contain and mitigate the pandemic. Identifying infected individuals helps to prevent further person-to-person transmission of the virus.
As everyone knows, health care services are struggling to meet the demand for polymerase chain reaction, or PCR, tests, because the omicron variant has a very high infection rate. Provinces and territories across the country are now relying on rapid tests to help fill this significant gap.
Rapid tests are a screening method that can more easily and quickly detect COVID-19 in a variety of settings such as schools, workplaces and other high-risk environments including long-term care facilities and hospitals, to name a few.
Using rapid tests in new settings can help detect the spread of COVID-19 and support measures to break the chain of transmission.
Not everyone who has COVID-19 will show symptoms. In fact, the prevalence of asymptomatic infection is probably a significant factor in the high rate of transmission of omicron. Rapid testing allows a person to detect the virus in as little as 15 minutes, which makes it a powerful tool that Canadians can use to help curb the spread of the omicron variant.
Since the introduction of Bill C-8, which provided additional funding for the purchase and distribution of rapid tests, Canada experienced an exponential increase in the number of cases and hospitalizations. The spread of omicron also led to an abrupt increase in demand for rapid tests. This is putting pressure on global supply, where supply chains are very tight, so clearly we need to get more of these tests, and we need to do it now.
Bill C-10 will allow Health Canada to purchase and distribute hundreds of millions of rapid tests across the country and help ensure equitable access in all jurisdictions. It also builds on commitments made in last December's economic and fiscal update, which included an additional $1.7 billion in funding for the procurement and distribution of rapid tests across the country.
Bill C-10 would also allow Health Canada and the Public Health Agency of Canada to continue supporting provinces and territories by securing the rapid tests that they need to keep Canadians safe and healthy, including through expanded schoolplace and workplace testing programs.
Finally, Bill C-10 would allow us to continue supporting businesses of all sizes by providing rapid tests for workplace screening programs through direct delivery and partners such as chambers of commerce and pharmacies.
Throughout the pandemic, the Canadian government has worked closely with its provincial and territorial partners to ensure they have the tools they need to manage outbreaks and ensure the safety and health of everyone.
The federal government starting buying and providing rapid tests free of charge to the provinces and territories in October 2020. The Government of Canada delivered more than 35 million rapid tests to provinces and territories in December 2021, and 140 million additional tests were delivered to Canada in January alone.
The Government of Canada also supports the Canadian Red Cross in its delivery efforts.
Companies with 200 employees or more, including federally regulated companies, can receive rapid tests free of charge directly from the Government of Canada. Small and medium-sized businesses and other organizations can also receive and have access to rapid tests through one of the Canadian government's delivery partners.
The Canadian government has spent the past two years enhancing its ability to respond quickly and efficiently to the many challenges associated with the pandemic.
Working with the provinces, territories and other partners, we are delivering the tools we need to protect Canadians in our health care system from the most serious outcomes of COVID-19.
As my colleagues know, this year started out with a marked increase in the number of COVID-19 cases when there was a surge in the omicron variant in Canada and around the world.
Recent modelling has shown that the increase in omicron infections has probably peaked. However, the number of daily admissions to hospitals and intensive care units is still high and many hospitals in Canada are under intense pressure.
Therefore, we must continue to do everything we can to limit the spread of COVID-19 and its variants.
In the short term, that means vaccines, boosters and strong adherence to public health guidelines.
Because nearly three million eligible Canadians have yet to get a first or second dose of the primary series and many other Canadians are also eligible for a booster, we want to improve our individual and collective protection with the COVID‑19 vaccines. This will help us keep fighting the omicron wave and any potential new waves and variants.
Looking ahead, Canada will need to continue to tackle future waves, which may or may not be smaller than the omicron surge depending on how the virus evolves.
Screening tests, combined with individual public health measures and vaccination, play an important role in protecting Canadians and reducing the risk of outbreaks, swiftly identifying and isolating cases, and limiting the spread of COVID‑19 and its variants of concern.
We are all tired after living with the COVID‑19 pandemic for the past two years and the most recent omicron wave. We all want to know when the pandemic will be over, but we cannot simply snap our fingers and decide that COVID‑19 is over.
We are at a critical juncture in the pandemic. We must do the right thing and act responsibly, and we need to do it now. We know that rapid tests will help us slow the spread of omicron. They will also help manage outbreaks and, ultimately, they will help keep Canadians safe and healthy.
That is why I urge all members of the House to support Bill C‑10.